| Patrick A Dunphy, PA | |
|
4311 E Lohman Ave, Las Cruces, NM 88011-8255 | |
| (505) 556-6800 | |
| Not Available |
| Full Name | Patrick A Dunphy |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Location | 4311 E Lohman Ave, Las Cruces, New Mexico |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104149541 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Patrick A Dunphy, PA 7 Fiore Cir, Latham, NY 12110-5635 Ph: (518) 210-1237 | Patrick A Dunphy, PA 4311 E Lohman Ave, Las Cruces, NM 88011-8255 Ph: (505) 556-6800 |
News Archive
An antibiotic candidate compound shelved in the 1970s in favour of more worthwhile drugs could be worth a second look, new research has found.
Orthopaedic surgeons face a steep learning curve to get used to new prostheses, and the instruments and methods that go with them, before new total knee replacement procedures are as safe and effective as conventional methods. Patients who undergo the first 15 operations using a new device in a hospital are 48 percent more likely to need early revision surgery, than patients undergoing an operation to fit a prosthesis previously used in the hospital.
For many cancer patients, a bone marrow biopsy and/or aspiration is one of the most dreaded aspects of their diagnosis and treatment plan. The traditional method for gaining bone marrow involves grinding a needle by hand and sheer force through a patient's skin and bone, and the procedure is often described as "brutal," "excruciating" and even "barbaric."
Sunesis Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has granted voreloxin orphan drug designation for the treatment of acute myeloid leukemia (AML). Sunesis is currently conducting two Phase 2 clinical trials of voreloxin in AML: a single-agent study, known as REVEAL-1, of voreloxin in newly diagnosed elderly AML patients unlikely to benefit from standard induction chemotherapy and a study evaluating voreloxin in combination with cytarabine in relapsed/refractory AML.
› Verified 9 days ago
Dominic Tellez, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 1600 Phtorpe Road, Las Cruces, NM 88012 Phone: 575-526-6200 Fax: 575-526-2266 | |
Calandria Reno, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 999 W Amador Ave Ste A, Las Cruces, NM 88005 Phone: 575-527-5482 Fax: 575-652-4243 | |
Britteni Nicole Romero, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 4351 E Lohman Ave Ste 310, Las Cruces, NM 88011 Phone: 575-532-9755 Fax: 575-532-8881 | |
Marcia Ann Jamison, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 2530 S Telshor Blvd, Suite 207, Las Cruces, NM 88011 Phone: 575-522-6806 Fax: 575-521-8033 | |
Mr. Francisco Javier Rodriguez Jr., PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 4351 E Lohman Ave Ste 301, Las Cruces, NM 88011 Phone: 575-532-9755 Fax: 575-532-8881 | |
Ms. Sofia Luisa Young, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 4311 E Lohman Ave, Las Cruces, NM 88011 Phone: 575-556-6800 |